Since the T-ALL cells expressed CCR7, it is tempting to speculate that the enhanced lifespan of treated mice is due to CCL198-83 blocking the CCR7-mediated migration of T-ALL cells into the mouse CNS, which is currently under investigation in our lab. Here, CCR7 is linked to acute lymphoblastic leukemia.